Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  1995-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00365529509093256PMID 7732340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis

  2005cited by this paper
• Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial.

  1993cited by this paper
• Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.

  1993cited by this paper
• A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.

  1992cited by this paper
• [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].

  1992cited by this paper
• Compliance with anti‐ulcer medication during short‐term healing phase clinical trials

  1992cited by this paper
• Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group.

  1991cited by this paper
• Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditions.

  1991cited by this paper
• The effect of perioperative blood transfusion on recurrence after primary operation for Crohn's disease.

  1991cited by this paper
• Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.

  1991cited by this paper
• Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.

  1990cited by this paper
• 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?

  1988cited by this paper
• Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositories

  1987cited by this paper
• A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

  1987cited by this paper
• Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis

  1987cited by this paper
• Osteoporosis in patients with inflammatory bowel disease.

  1987cited by this paper
• 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

  1987cited by this paper
• Retrograde spreading of hydrocortisone enema in inflammatory bowel disease

  1986cited by this paper
• 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.

  1986cited by this paper
• Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas.

  1985cited by this paper
• Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

  1981cited by this paper
• Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam.

  1980cited by this paper
• Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

  1980cited by this paper
• Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

  1979cited by this paper
• An experiment to determine the active therapeutic moiety of sulphasalazine.

  1977cited by this paper
• A BISHOP'S SENSE AND NONSENSE

  1960cited by this paper
• Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

  1958cited by this paper
• Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

  1958cited by this paper
• Enteric fever apparently spread by pasteurized milk.

  1948cited by this paper

• British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

  2025cites this paper
• Long-Term Course and Prognostic Factors in Pediatric Ulcerative Proctitis: A Multicenter Cohort Study

  2024cites this paper
• 3D printed infliximab suppositories for rectal biologic delivery

  2023cites this paper
• Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis

  2023cites this paper
• Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial

  2022cites this paper
• ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

  2021cites this paper
• Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review.

  2021cites this paper
• Drug development for ulcerative proctitis: current concepts

  2021cites this paper
• First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus

  2020cites this paper
• Steroid use and misuse: a key performance indicator in the management of IBD

  2020cites this paper
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease

  2020cites this paper
• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

  2019cites this paper
• AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

  2019cites this paper
• Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis

  2019cites this paper
• Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis

  2019cites this paper
• Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis

  2018cites this paper
• American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis

  2018cites this paper
• Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository

  2018cites this paper
• Second Korean guidelines for the management of ulcerative colitis

  2017cites this paper
• Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis

  2017cites this paper
• [Second Korean Guideline for the Management of Ulcerative Colitis].

  2017cites this paper
• Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta‐analysis

  2017cites this paper
• Improvement of side-effects and treatment on the experimental colitis in mice of a resin microcapsule-loading hydrocortisone sodium succinate

  2017cites this paper
• Non-Hospitalized 1 Ulcerative Colitis : The Toronto Consensus 2 3

  2015cites this paper
• Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

  2015cites this paper
• Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?

  2015cites this paper
• Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.

  2014cites this paper
• Treatment of inflammatory bowel disease: is your patient at risk of non-adherence?

  2014influential citation
• Rectal Glucocorticoid Use in Ulcerative Colitis

  2014cites this paper
• Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn’s disease

  2014cites this paper
• Medication Adherence in Ulcerative Colitis

  2014cites this paper
• Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices

  2014cites this paper
• Drug Therapies for Ulcerative Proctitis: Systematic Review and Meta-analysis

  2014cites this paper
• Tract afety and efficacy of sodium hyaluronate ( IBD 98 E ) in the induction f clinical and endoscopic remission in subjects with distal lcerative colitis

  2014cites this paper
• High mucosal healing rates in 5‐ASA‐treated ulcerative colitis patients: Results of a meta‐analysis of clinical trials

  2012cites this paper
• How Important is Onset of Action in Ulcerative Colitis Therapy?

  2012cites this paper
• Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis

  2012cites this paper
• Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men

  2012cites this paper
• Tolerability of Aminosalicylates in Inflammatory Bowel Disease

  2012cites this paper
• The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

  2011cites this paper
• Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz

  2011cites this paper
• State of the Art Medical Treatment of the Adult Patient with IBD: Modern Use of Corticosteroids

  2011cites this paper
• Self‐reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis

  2011cites this paper
• Self‐reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease

  2010cites this paper
• Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents

  2010cites this paper
• Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  2010cites this paper
• Self-reported treatment adherence in inflammatory bowel disease in Indian patients

  2009cites this paper
• Patient Adherence in Inflammatory Bowel Disease

  2008cites this paper
• Nonadherence With Thiopurine Immunomodulator and Mesalamine Medications in Children with Crohn Disease

  2007cites this paper
• A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.

  2007cites this paper
• A Suppository Chinese Medicine (Xilei-san) for Refractory Ulcerative Proctitis: A Pilot Clinical Trial

  2007cites this paper
• Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease

  2006cites this paper
• [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].

  2006cites this paper
• Review article: how to control and improve adherence to therapy in inflammatory bowel disease

  2006cites this paper
• Optimizing management of distal ulcerative colitis

  2006cites this paper
• Medical management of left‐sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

  2006cites this paper
• Chapter Fifty-Seven – Ulcerative colitis

  2006cites this paper
• Aminosalicylate und Steroide in der Behandlung von chronisch entzündlichen Darmerkrankungen - Konsensuspapier der Arbeitsgruppe für chronisch entzündliche Darmerkrankungen der ÖGGH

  2006cites this paper
• Mesalamine delivery systems: do they really make much difference?

  2005cites this paper
• Pharmacokinetics and Pilot Efficacy of a Mesalazine Rectal Gel in Distal Ulcerative Colitis

  2005cites this paper
• Adherence to treatment in inflammatory bowel disease.

  2005cites this paper
• Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease

  2004influential citation
• Ulcerative Proctitis

  2004cites this paper
• General principles of medical therapy of inflammatory bowel disease.

  2004cites this paper
• Diagnosis and treatment of ulcerative proctitis.

  2004cites this paper
• Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial – is gastro‐oesophageal reflux important?

  2004cites this paper
• Traitement de la rectocolite ulcéro-hémorragique dans sa forme distale

  2004cites this paper
• [The treatment of distal ulcerative colitis].

  2004cites this paper
• Clustering patients according to health perceptions: relationships to psychosocial characteristics and medication nonadherence.

  2004cites this paper
• Medical management of ulcerative colitis

  2003cites this paper
• Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients

  2003cites this paper
• Patient nonadherence to medication in inflammatory bowel disease.

  2003cites this paper
• Medical therapy of inflammatory bowel disease for the 21st century.

  2003cites this paper
• Patient nonadherence to medication in inflammatory bowel disease

  2003cites this paper
• 30 Medical management of ulcerative colitis

  2003cites this paper
• Inflammatory bowel disease. Medical therapy of specific clinical presentations.

  2002cites this paper
• Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

  2002cites this paper
• Effect of Budesonide Enema on Remission and Relapse Rate in Distal Ulcerative Colitis and Proctitis

  2002cites this paper
• REVIEW: Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease: A Systemic Review

  2002cites this paper
• Single subject trials as a research instrument in gastrointestinal pharmacology

  2002cites this paper
• H2‐receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta‐analysis of randomized controlled clinical trials

  2001cites this paper
• THE MANAGEMENT OF REFRACTORY DISTAL COLITIS

  2001cites this paper
• Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

  2000cites this paper
• [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].

  2000cites this paper
• Clinical Pharmacokinetics of Slow Release Mesalazine

  2000cites this paper
• Identifying responders to acid suppression in dyspepsia using a random starting day trial

  2000cites this paper
• Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis

  2000cites this paper
• Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study.

  2000cites this paper
• A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis

  2000cites this paper
• Clinical pharmacokinetics of slow release mesalazine.

  2000cites this paper
• Comparative, open, randomized trial of the efficacy and tolerance of slow- release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis

  2000cites this paper
• Budesonid-Schaum als neues Therapieprinzip bei der distalen Colitis ulcerosa im Vergleich mit Mesalazin-Klysmen. Eine offene, kontrollierte, randomisierte und prospektive multizentrische Pilotstudie

  2000cites this paper
• Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.

  1999cites this paper
• Medical therapy of specific clinical presentations.

  1999cites this paper
• Patient compliance and outcomes.

  1999cites this paper
• Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998

  1999cites this paper
• Dyspepsia: current understanding and management.

  1998cites this paper
• Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies)

  1998cites this paper
• Oral or rectal administration of drugs in IBD?

  1997cites this paper
• Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

  1997cites this paper